Exvastat

Developer of repurposed drug for acute respiratory distress syndrome

placeCambridge, England, United Kingdom calendar_todayFounded 2016 groups8 employees language exvastat.com

Registered entities

Innovation

2 patent families (1 granted) — focus: Human necessities; filing pace slowing. Cited 11 times.

YearFilings
20221
20232

Investor mix

12 investors on record; lead investors include Cambridge Innovation Capital.

Investor typeCountShare
Venture capital18%
Accelerator & incubator18%
Other / undisclosed1083%
Coming soon